Efficacy and safety of paclitaxel and carboplatin with bevacizumab for the first-line treatment of patients with nonsquamous non-small cell lung cancer (NSCLC): Analyses based on age in the phase III PointBreak and E4599 trials.
Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Abramson Cancer Center, University of Pennsylvania, University of Pittsburgh Medical Center, Northwestern University, OHSU Knight Cancer Institute, Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Genentech, Emory University, Winship Cancer Institute
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2529057575